Switch from enzyme replacement therapy to oral chaperone migalastat for treating fabry disease: real-life data.
Eur J Hum Genet
; 28(12): 1662-1668, 2020 12.
Article
in En
| MEDLINE
| ID: mdl-32647377
Full text:
1
Database:
MEDLINE
Therapeutic Methods and Therapies TCIM:
Terapias_biologicas
/
Aromoterapia
Main subject:
Fabry Disease
/
1-Deoxynojirimycin
/
Drug-Related Side Effects and Adverse Reactions
Type of study:
Observational_studies
Language:
En
Journal:
Eur J Hum Genet
Year:
2020
Type:
Article
Affiliation country:
Italy